110 related articles for article (PubMed ID: 7657533)
1. Cell contacts, differentiation, and invasiveness of epithelial cells.
Behrens J
Invasion Metastasis; 1994-1995; 14(1-6):61-70. PubMed ID: 7657533
[TBL] [Abstract][Full Text] [Related]
2. Molecular aspects of the loss of cell adhesion and gain of invasiveness in carcinomas.
Birchmeier W
Princess Takamatsu Symp; 1994; 24():214-32. PubMed ID: 8983077
[TBL] [Abstract][Full Text] [Related]
3. Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis.
Christiansen JJ; Rajasekaran AK
Cancer Res; 2006 Sep; 66(17):8319-26. PubMed ID: 16951136
[TBL] [Abstract][Full Text] [Related]
4. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
Zhang H; Stephens LC; Kumar R
Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
[TBL] [Abstract][Full Text] [Related]
5. Regulation of urokinase plasminogen activator (uPA) activity by E-cadherin and hormones in mammary epithelial cells.
Sasaki CY; Lin H; Passaniti A
J Cell Physiol; 1999 Oct; 181(1):1-13. PubMed ID: 10457348
[TBL] [Abstract][Full Text] [Related]
6. Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.
Jeschke U; Mylonas I; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
Anticancer Res; 2005; 25(3A):1615-22. PubMed ID: 16033070
[TBL] [Abstract][Full Text] [Related]
7. Modulation of E-cadherin localization in cells expressing wild-type E1A 12S or hypertransforming mutants.
Gopalakrishnan S; Quinlan MP
Cell Growth Differ; 1995 Aug; 6(8):985-98. PubMed ID: 8547227
[TBL] [Abstract][Full Text] [Related]
8. Expression of E-cadherin is associated with squamous differentiation in squamous cell carcinomas.
Wu H; Lotan R; Menter D; Lippman SM; Xu XC
Anticancer Res; 2000; 20(3A):1385-90. PubMed ID: 10928048
[TBL] [Abstract][Full Text] [Related]
9. Molecular mechanisms leading to cell junction (cadherin) deficiency in invasive carcinomas.
Birchmeier W; Weidner KM; Hülsken J; Behrens J
Semin Cancer Biol; 1993 Aug; 4(4):231-9. PubMed ID: 8400145
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms of invasion and metastasis during mouse skin tumour progression.
Portella G; Liddell J; Crombie R; Haddow S; Clarke M; Stoler AB; Balmain A
Invasion Metastasis; 1994-1995; 14(1-6):7-16. PubMed ID: 7657534
[TBL] [Abstract][Full Text] [Related]
11. Defective E-cadherin function in urological cancers: clinical implications and molecular mechanisms.
Giroldi LA; Bringuier PP; Schalken JA
Invasion Metastasis; 1994-1995; 14(1-6):71-81. PubMed ID: 7657535
[TBL] [Abstract][Full Text] [Related]
12. [Cell communication in the development of the oral cavity].
Tripi TR; Bonaccorso A
Minerva Stomatol; 1998 Oct; 47(10):519-26. PubMed ID: 9866965
[TBL] [Abstract][Full Text] [Related]
13. E-cadherin mRNA expression in breast carcinomas correlates with overall and disease-free survival.
Guriec N; Marcellin L; Gairard B; Caldéroli H; Wilk A; Renaud R; Bergerat JP; Oberling F
Invasion Metastasis; 1996; 16(1):19-26. PubMed ID: 8830762
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical expression of extracellular matrix proteins and adhesion molecules in pancreatic carcinoma.
Linder S; Castaños-Velez E; von Rosen A; Biberfeld P
Hepatogastroenterology; 2001; 48(41):1321-7. PubMed ID: 11677955
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic carcinoma: correlation between E-cadherin and alpha-catenin expression status and liver metastasis.
Gunji N; Oda T; Todoroki T; Kanazawa N; Kawamoto T; Yuzawa K; Scarpa A; Fukao K
Cancer; 1998 May; 82(9):1649-56. PubMed ID: 9576284
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ.
De Leeuw WJ; Berx G; Vos CB; Peterse JL; Van de Vijver MJ; Litvinov S; Van Roy F; Cornelisse CJ; Cleton-Jansen AM
J Pathol; 1997 Dec; 183(4):404-11. PubMed ID: 9496256
[TBL] [Abstract][Full Text] [Related]
17. A causal role for E-cadherin in the transition from adenoma to carcinoma.
Perl AK; Wilgenbus P; Dahl U; Semb H; Christofori G
Nature; 1998 Mar; 392(6672):190-3. PubMed ID: 9515965
[TBL] [Abstract][Full Text] [Related]
18. Over-expression of EphB3 enhances cell-cell contacts and suppresses tumor growth in HT-29 human colon cancer cells.
Chiu ST; Chang KJ; Ting CH; Shen HC; Li H; Hsieh FJ
Carcinogenesis; 2009 Sep; 30(9):1475-86. PubMed ID: 19483190
[TBL] [Abstract][Full Text] [Related]
19. The role of the matricellular protein SPARC in the dynamic interaction between the tumor and the host.
Podhajcer OL; Benedetti L; Girotti MR; Prada F; Salvatierra E; Llera AS
Cancer Metastasis Rev; 2008 Sep; 27(3):523-37. PubMed ID: 18459035
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor-beta1 promotes invasiveness after cellular transformation with activated Ras in intestinal epithelial cells.
Fujimoto K; Sheng H; Shao J; Beauchamp RD
Exp Cell Res; 2001 Jun; 266(2):239-49. PubMed ID: 11399052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
